Theravance Biopharma, Inc.
← Back to TBPH Overview

Theravance Biopharma, Inc. (TBPH)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

3.90

Financial Fundamentals

TBPHQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2012-09-30-5.59
2012-12-31-6.24
2013-03-31-5.76
2013-06-30-4.68
2013-09-30-4.44
2013-12-31-4.13
2014-03-31-3.04
2014-06-30-4.35
2014-09-30-3.36
2014-12-31-1.84
2015-03-31-3.35
2015-06-30-2.29
2015-09-30-1.96
2015-12-31-3.34
2016-03-31-4.27
2016-06-30-5.33
2016-09-30-12.40
2016-12-31-5.87
2017-03-31-7.27
2017-06-30-7.85
2017-09-30-6.73
2017-12-31-4.24
2018-03-31-4.96
2018-06-30-7.47
2018-09-30-7.59
2018-12-31-6.95
2019-03-31-4.45
2019-06-30-5.90
2019-09-30-4.66
2019-12-31-5.53
2020-03-31-4.14
2020-06-30-5.25
2020-09-30-3.18
2020-12-31-4.84
2021-03-31-4.13
2021-06-30-4.55
2021-09-30-3.85
2021-12-31-6.35
2022-03-31-6.93
2022-06-30-21.09
2022-09-300.21
2022-12-31-18.24
2023-03-31-7.73
2023-06-30-9.37
2023-09-30-12.62
2023-12-31-16.32
2024-03-31-9.34
2024-06-30-6.28
2024-09-30-7.78
2024-12-31-7.47
2025-03-31-8.17
2025-06-302.52
2025-09-3051.01
2025-12-313.90

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Theravance Biopharma, Inc. (TBPH) P/E Ratio History & Valuation Cycles